Report Detail

Pharma & Healthcare Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025

  • RnM2306867
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Large Volume Parenteral (LVP) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Product
      • 1.4.2 Fluid Balance Injections
      • 1.4.3 Therapeutic Injections
      • 1.4.4 Nutritious Injections
    • 1.5 Market by End User
      • 1.5.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Medical Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Large Volume Parenteral (LVP) Market Size
      • 2.1.1 Global Large Volume Parenteral (LVP) Revenue 2014-2025
      • 2.1.2 Global Large Volume Parenteral (LVP) Sales 2014-2025
    • 2.2 Large Volume Parenteral (LVP) Growth Rate by Regions
      • 2.2.1 Global Large Volume Parenteral (LVP) Sales by Regions
      • 2.2.2 Global Large Volume Parenteral (LVP) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Large Volume Parenteral (LVP) Sales by Manufacturers
      • 3.1.1 Large Volume Parenteral (LVP) Sales by Manufacturers
      • 3.1.2 Large Volume Parenteral (LVP) Sales Market Share by Manufacturers
      • 3.1.3 Global Large Volume Parenteral (LVP) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Large Volume Parenteral (LVP) Revenue by Manufacturers
      • 3.2.1 Large Volume Parenteral (LVP) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Large Volume Parenteral (LVP) Price by Manufacturers
    • 3.4 Large Volume Parenteral (LVP) Manufacturing Base Distribution, Product Types
      • 3.4.1 Large Volume Parenteral (LVP) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Large Volume Parenteral (LVP) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Large Volume Parenteral (LVP) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Large Volume Parenteral (LVP) Sales by Product
    • 4.2 Global Large Volume Parenteral (LVP) Revenue by Product
    • 4.3 Large Volume Parenteral (LVP) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Large Volume Parenteral (LVP) Breakdown Data by End User

    6 North America

    • 6.1 North America Large Volume Parenteral (LVP) by Countries
      • 6.1.1 North America Large Volume Parenteral (LVP) Sales by Countries
      • 6.1.2 North America Large Volume Parenteral (LVP) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Large Volume Parenteral (LVP) by Product
    • 6.3 North America Large Volume Parenteral (LVP) by End User

    7 Europe

    • 7.1 Europe Large Volume Parenteral (LVP) by Countries
      • 7.1.1 Europe Large Volume Parenteral (LVP) Sales by Countries
      • 7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Large Volume Parenteral (LVP) by Product
    • 7.3 Europe Large Volume Parenteral (LVP) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Large Volume Parenteral (LVP) by Countries
      • 8.1.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Countries
      • 8.1.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Large Volume Parenteral (LVP) by Product
    • 8.3 Asia Pacific Large Volume Parenteral (LVP) by End User

    9 Central & South America

    • 9.1 Central & South America Large Volume Parenteral (LVP) by Countries
      • 9.1.1 Central & South America Large Volume Parenteral (LVP) Sales by Countries
      • 9.1.2 Central & South America Large Volume Parenteral (LVP) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Large Volume Parenteral (LVP) by Product
    • 9.3 Central & South America Large Volume Parenteral (LVP) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Large Volume Parenteral (LVP) by Countries
      • 10.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Countries
      • 10.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Large Volume Parenteral (LVP) by Product
    • 10.3 Middle East and Africa Large Volume Parenteral (LVP) by End User

    11 Company Profiles

    • 11.1 Ostuka Pharmaceutical
      • 11.1.1 Ostuka Pharmaceutical Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
      • 11.1.5 Ostuka Pharmaceutical Recent Development
    • 11.2 Teva Pharmaceutical Industries
      • 11.2.1 Teva Pharmaceutical Industries Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
      • 11.2.5 Teva Pharmaceutical Industries Recent Development
    • 11.3 Kelun Pharma
      • 11.3.1 Kelun Pharma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
      • 11.3.5 Kelun Pharma Recent Development
    • 11.4 Cook Pharmica
      • 11.4.1 Cook Pharmica Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
      • 11.4.5 Cook Pharmica Recent Development
    • 11.5 Patheon
      • 11.5.1 Patheon Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Patheon Large Volume Parenteral (LVP) Products Offered
      • 11.5.5 Patheon Recent Development
    • 11.6 BAG Healthcare
      • 11.6.1 BAG Healthcare Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 BAG Healthcare Large Volume Parenteral (LVP) Products Offered
      • 11.6.5 BAG Healthcare Recent Development
    • 11.7 Southwest Pharmaceutical
      • 11.7.1 Southwest Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Southwest Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Southwest Pharmaceutical Large Volume Parenteral (LVP) Products Offered
      • 11.7.5 Southwest Pharmaceutical Recent Development
    • 11.8 Cook Pharmica
      • 11.8.1 Cook Pharmica Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Cook Pharmica Large Volume Parenteral (LVP) Products Offered
      • 11.8.5 Cook Pharmica Recent Development
    • 11.9 Beximco Pharma
      • 11.9.1 Beximco Pharma Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Beximco Pharma Large Volume Parenteral (LVP) Products Offered
      • 11.9.5 Beximco Pharma Recent Development
    • 11.10 Baxter Healthcare Corporation
      • 11.10.1 Baxter Healthcare Corporation Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Baxter Healthcare Corporation Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Baxter Healthcare Corporation Large Volume Parenteral (LVP) Products Offered
      • 11.10.5 Baxter Healthcare Corporation Recent Development

    12 Future Forecast

    • 12.1 Large Volume Parenteral (LVP) Market Forecast by Regions
      • 12.1.1 Global Large Volume Parenteral (LVP) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Regions 2019-2025
    • 12.2 Large Volume Parenteral (LVP) Market Forecast by Product
      • 12.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Product 2019-2025
    • 12.3 Large Volume Parenteral (LVP) Market Forecast by End User
    • 12.4 North America Large Volume Parenteral (LVP) Forecast
    • 12.5 Europe Large Volume Parenteral (LVP) Forecast
    • 12.6 Asia Pacific Large Volume Parenteral (LVP) Forecast
    • 12.7 Central & South America Large Volume Parenteral (LVP) Forecast
    • 12.8 Middle East and Africa Large Volume Parenteral (LVP) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Large Volume Parenteral (LVP) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.
      Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.
      Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
      The factors driving this market include increasing hospitalization rate and rise in demand for faster, safer and effective administration of drugs. The introduction of single dosage nervous system disorders, oncology and diabetes would provide opportunities for growth of this market.
      The global Large Volume Parenteral (LVP) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Large Volume Parenteral (LVP) market based on company, product type, end user and key regions.

      This report studies the global market size of Large Volume Parenteral (LVP) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Large Volume Parenteral (LVP) in these regions.
      This research report categorizes the global Large Volume Parenteral (LVP) market by top players/brands, region, type and end user. This report also studies the global Large Volume Parenteral (LVP) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Ostuka Pharmaceutical
      Teva Pharmaceutical Industries
      Kelun Pharma
      Cook Pharmica
      Patheon
      BAG Healthcare
      Southwest Pharmaceutical
      Cook Pharmica
      Beximco Pharma
      Baxter Healthcare Corporation

      Market size by Product
      Fluid Balance Injections
      Therapeutic Injections
      Nutritious Injections
      Market size by End User
      Hospitals
      Medical Centers
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Large Volume Parenteral (LVP) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Large Volume Parenteral (LVP) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Large Volume Parenteral (LVP) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Large Volume Parenteral (LVP) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Large Volume Parenteral (LVP) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Parenteral (LVP) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Large Volume Parenteral (LVP) . Industry analysis & Market Report on Large Volume Parenteral (LVP) is a syndicated market report, published as Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Large Volume Parenteral (LVP) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,084.51
      4,626.76
      6,169.01
      3,465.47
      5,198.21
      6,930.95
      422,646.90
      633,970.35
      845,293.80
      271,760.58
      407,640.87
      543,521.16
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report